B, B, H, & B Inc’s Encompass Health EHC Stock Holding History

B, B, H, & B Inc’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-312	Closed	-$20K	–	57
2020 Q4	$20K	Buy	+312	New	+$18.4K	0.02%	81

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

B, B, H, & B Inc's EHC Position: Q1 2021 in Review

B, B, H, & B Inc sold out of Encompass Health (EHC) in Q1 2021, closing a stake of 312 shares — an estimated $20K sold.

B, B, H, & B Inc first reported a position in EHC in Q4 2020 and held it in 1 quarter. The position peaked at $20K in Q4 2020. 403 funds tracked by Wall St. Rank hold EHC as of Q1 2021.

B, B, H, & B Inc reported no remaining Encompass Health position as of Q1 2021 after selling out during the quarter.
B, B, H, & B Inc sold 312 Encompass Health shares in Q1 2021, an estimated $20K.
B, B, H, & B Inc first reported a position in Encompass Health in Q4 2020 and held it in 1 quarter.
B, B, H, & B Inc's Encompass Health position peaked at $20K in Q4 2020.
403 funds tracked by Wall St. Rank held Encompass Health as of Q1 2021.

Based on B, B, H, & B Inc's 13F filing for Q1 2021, filed 11 May 2021.